"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","20/76","106/2914",5.59339746137131e-13,3.10433559106108e-10,2.09605210131388e-10,"RHOA/ARHGAP11A/MYO9B/STARD8/GMIP/ARHGEF10/ARHGAP31/ARHGAP1/ARHGEF1/ARHGEF2/ARHGAP22/ARHGDIG/ARHGAP6/ARHGAP21/ARHGAP20/TAGAP/MYO9A/ARHGAP19/ARHGEF5/ARHGAP10",20
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","26/76","228/2914",1.98855271714993e-11,5.51823379009105e-09,3.72591982792302e-09,"RHOA/MAPK14/MAPK3/PPP2CA/ROCK2/ARHGAP11A/PLK1/MYO9B/STARD8/PAK1/GMIP/ARHGEF10/ARHGAP31/ARHGAP1/ARHGEF1/ARHGEF2/ARHGAP22/ARHGDIG/ARHGAP6/ARHGAP21/ARHGAP20/TAGAP/MYO9A/ARHGAP19/ARHGEF5/ARHGAP10",26
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","31/76","347/2914",7.92564487175728e-11,1.4662443012751e-08,9.90010376963365e-09,"RHOA/MAPK14/MAPK3/PPP2CA/AKT1/YAP1/ROCK2/FLT3LG/JAK2/ERBB2/STAT3/CHEK1/AKT2/NRG4/STAT6/AKT3/FGF4/MAPKAPK2/FGF7/VEGFD/FGF18/PAK1/FGF17/NTF4/NRG1/FGF9/FGF5/VEGFC/FGF22/FGF20/PDGFD",31
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","16/76","99/2914",1.89581258229228e-09,2.63043995793054e-07,1.77607705077908e-07,"MAPK3/PPP2CA/AKT1/ERBB2/AKT2/NRG4/AKT3/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",16
"R-HSA-2033519","R-HSA-2033519","Activated point mutants of FGFR2","8/76","17/2914",2.9705866019057e-09,3.00187979724836e-07,2.02687379387466e-07,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","10/76","32/2914",3.24527545648472e-09,3.00187979724836e-07,2.02687379387466e-07,"MAPK3/PPP2CA/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",10
"R-HSA-190241","R-HSA-190241","FGFR2 ligand binding and activation","8/76","18/2914",5.23579896020272e-09,3.33158876430925e-07,2.24949378870383e-07,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-5654221","R-HSA-5654221","Phospholipase C-mediated cascade; FGFR2","8/76","18/2914",5.23579896020272e-09,3.33158876430925e-07,2.24949378870383e-07,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","20/76","172/2914",5.40257637455554e-09,3.33158876430925e-07,2.24949378870383e-07,"TP53/MAPK3/PPP2CA/AKT1/CSNK2A1/NR4A1/ERBB2/AKT2/NRG4/AKT3/FGF4/FGF7/FGF18/FGF17/NRG1/PREX2/FGF9/FGF5/FGF22/FGF20",20
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","15/76","97/2914",1.23398975842248e-08,6.84864315924476e-07,4.62421425261477e-07,"AKT1/NR4A1/ERBB2/AKT2/NRG4/AKT3/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",15
"R-HSA-1839126","R-HSA-1839126","FGFR2 mutant receptor activation","8/76","22/2914",3.51749313921921e-08,1.77473517478787e-06,1.19830388283449e-06,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","11/76","52/2914",4.66105828791233e-08,1.83193337719053e-06,1.23692419588398e-06,"MAPK3/FLT3LG/AKT2/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",11
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","11/76","52/2914",4.66105828791233e-08,1.83193337719053e-06,1.23692419588398e-06,"MAPK3/FLT3LG/AKT2/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",11
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","14/76","92/2914",5.00948671127933e-08,1.83193337719053e-06,1.23692419588398e-06,"MAPK3/PPP2CA/AKT1/ERBB2/NRG4/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",14
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","8/76","23/2914",5.28124937568441e-08,1.83193337719053e-06,1.23692419588398e-06,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-5654699","R-HSA-5654699","SHC-mediated cascade:FGFR2","8/76","23/2914",5.28124937568441e-08,1.83193337719053e-06,1.23692419588398e-06,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-109704","R-HSA-109704","PI3K Cascade","10/76","42/2914",6.0029546815573e-08,1.95978814603782e-06,1.32325192980458e-06,"FLT3LG/AKT2/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",10
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","20/76","201/2914",8.21773869838632e-08,2.53380276533578e-06,1.71082747171084e-06,"TP53/MAPK3/PPP2CA/AKT1/CSNK2A1/NR4A1/ERBB2/AKT2/NRG4/AKT3/FGF4/FGF7/FGF18/FGF17/NRG1/PREX2/FGF9/FGF5/FGF22/FGF20",20
"R-HSA-5654700","R-HSA-5654700","FRS-mediated FGFR2 signaling","8/76","25/2914",1.116996913873e-07,3.14096381407278e-06,2.12078353306763e-06,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","23/76","268/2914",1.13187885191812e-07,3.14096381407278e-06,2.12078353306763e-06,"NOTCH1/SMAD3/MAPK3/PPP2CA/AKT1/EP300/JAK2/NR4A1/ERBB2/STAT3/SMAD4/AKT2/NRG4/AKT3/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",23
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","10/76","46/2914",1.52921075837657e-07,4.04148557570951e-06,2.72881719289253e-06,"FLT3LG/AKT2/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",10
"R-HSA-1839130","R-HSA-1839130","Signaling by activated point mutants of FGFR3","6/76","12/2914",2.10709886157184e-07,4.67775947268947e-06,3.1584302935561e-06,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-190239","R-HSA-190239","FGFR3 ligand binding and activation","6/76","12/2914",2.10709886157184e-07,4.67775947268947e-06,3.1584302935561e-06,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-190372","R-HSA-190372","FGFR3c ligand binding and activation","6/76","12/2914",2.10709886157184e-07,4.67775947268947e-06,3.1584302935561e-06,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-2033514","R-HSA-2033514","FGFR3 mutant receptor activation","6/76","12/2914",2.10709886157184e-07,4.67775947268947e-06,3.1584302935561e-06,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","8/76","27/2914",2.19834090313968e-07,4.69261231247123e-06,3.16845895351306e-06,"MAPK3/PPP2CA/FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",8
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","10/76","50/2914",3.54339808547207e-07,7.02352120513213e-06,4.74229217454156e-06,"FLT3LG/AKT2/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",10
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","10/76","50/2914",3.54339808547207e-07,7.02352120513213e-06,4.74229217454156e-06,"MAPK3/PPP2CA/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",10
"R-HSA-190375","R-HSA-190375","FGFR2c ligand binding and activation","6/76","13/2914",3.83251395734008e-07,7.09015082107915e-06,4.78728059232656e-06,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-5654227","R-HSA-5654227","Phospholipase C-mediated cascade; FGFR3","6/76","13/2914",3.83251395734008e-07,7.09015082107915e-06,4.78728059232656e-06,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","10/76","51/2914",4.31611511283441e-07,7.48576214882219e-06,5.05439796108241e-06,"FLT3LG/AKT2/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",10
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","10/76","51/2914",4.31611511283441e-07,7.48576214882219e-06,5.05439796108241e-06,"FLT3LG/AKT2/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",10
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","8/76","30/2914",5.44122871366837e-07,8.88200569437043e-06,5.99714372156638e-06,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","8/76","30/2914",5.44122871366837e-07,8.88200569437043e-06,5.99714372156638e-06,"MAPK3/PPP2CA/FGF4/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","9/76","41/2914",6.18041878227802e-07,9.80037835475514e-06,6.6172303353112e-06,"MAPK3/PPP2CA/FGF4/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",9
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","10/76","55/2914",9.0841155319995e-07,1.40046781118326e-05,9.45597991050241e-06,"MAPK3/PPP2CA/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",10
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","8/76","32/2914",9.37561626095574e-07,1.40634243914336e-05,9.49564548762516e-06,"FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",8
"R-HSA-190242","R-HSA-190242","FGFR1 ligand binding and activation","6/76","15/2914",1.07221478831092e-06,1.56599791450674e-05,1.0573641679742e-05,"FGF4/FGF17/FGF9/FGF5/FGF22/FGF20",6
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","9/76","45/2914",1.43712904672279e-06,2.04514518187475e-05,1.38088512991448e-05,"STAT3/FGF4/FGF7/FGF18/FGF17/FGF9/FGF5/FGF22/FGF20",9
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","11/76","72/2914",1.53522494380755e-06,2.13012460953298e-05,1.43826336840918e-05,"ERBB2/NRG4/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",11
"R-HSA-5654219","R-HSA-5654219","Phospholipase C-mediated cascade: FGFR1","6/76","16/2914",1.6801944540832e-06,2.27440956589311e-05,1.53568478986809e-05,"FGF4/FGF17/FGF9/FGF5/FGF22/FGF20",6
"R-HSA-5658623","R-HSA-5658623","FGFRL1 modulation of FGFR1 signaling","5/76","10/2914",2.40775274583723e-06,3.18167327128491e-05,2.148270620346e-05,"FGF4/FGF18/FGF17/FGF5/FGF22",5
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","8/76","37/2914",3.09781298364436e-06,3.99834001377353e-05,2.6996852440083e-05,"MAPK3/PPP2CA/FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",8
"R-HSA-5654704","R-HSA-5654704","SHC-mediated cascade:FGFR3","6/76","18/2914",3.73617306352168e-06,4.6079467783434e-05,3.11129265640635e-05,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","6/76","18/2914",3.73617306352168e-06,4.6079467783434e-05,3.11129265640635e-05,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","5/76","11/2914",4.32456930580932e-06,5.00028325984203e-05,3.37619884400903e-05,"AKT1/ERBB2/AKT2/AKT3/NRG1",5
"R-HSA-1839122","R-HSA-1839122","Signaling by activated point mutants of FGFR1","5/76","11/2914",4.32456930580932e-06,5.00028325984203e-05,3.37619884400903e-05,"FGF4/FGF17/FGF9/FGF5/FGF20",5
"R-HSA-190373","R-HSA-190373","FGFR1c ligand binding and activation","5/76","11/2914",4.32456930580932e-06,5.00028325984203e-05,3.37619884400903e-05,"FGF4/FGF17/FGF9/FGF5/FGF20",5
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","7/76","28/2914",4.7409034985894e-06,5.36979886064718e-05,3.6256963383412e-05,"MAPK3/PPP2CA/FGF4/FGF18/FGF17/FGF9/FGF20",7
"R-HSA-5654706","R-HSA-5654706","FRS-mediated FGFR3 signaling","6/76","20/2914",7.48281739340296e-06,8.27282340411779e-05,5.58582291487138e-05,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","16/76","177/2914",7.60205393891905e-06,8.27282340411779e-05,5.58582291487138e-05,"MAPK3/PPP2CA/CDK1/FLT3LG/JAK2/ERBB2/NRG4/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",16
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","17/76","202/2914",9.95466148973776e-06,0.000105452696894084,7.12018209469772e-05,"MAPK3/PPP2CA/CDK1/FLT3LG/JAK2/ERBB2/NRG4/FGF4/FGF7/FGF18/PAK1/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",17
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","6/76","21/2914",1.02602624005054e-05,0.000105452696894084,7.12018209469772e-05,"FGF4/FGF17/FGF9/FGF5/FGF22/FGF20",6
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","6/76","21/2914",1.02602624005054e-05,0.000105452696894084,7.12018209469772e-05,"FGF4/FGF17/FGF9/FGF5/FGF22/FGF20",6
"R-HSA-190322","R-HSA-190322","FGFR4 ligand binding and activation","5/76","13/2914",1.15629083974169e-05,0.000116680257464843,7.87826868800081e-05,"FGF4/FGF18/FGF17/FGF9/FGF20",5
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","6/76","22/2914",1.38174537320827e-05,0.000134538365286069,9.08405083771275e-05,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","6/76","22/2914",1.38174537320827e-05,0.000134538365286069,9.08405083771275e-05,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","16/76","188/2914",1.66052870533696e-05,0.000158895419217588,0.000107286428148812,"MAPK3/PPP2CA/FLT3LG/JAK2/ERBB2/AKT2/NRG4/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",16
"R-HSA-5654228","R-HSA-5654228","Phospholipase C-mediated cascade; FGFR4","5/76","14/2914",1.76218209016803e-05,0.000163001843340543,0.000110059091947337,"FGF4/FGF18/FGF17/FGF9/FGF20",5
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","5/76","14/2914",1.76218209016803e-05,0.000163001843340543,0.000110059091947337,"TP53/AKT1/EP300/AKT2/AKT3",5
"R-HSA-5654693","R-HSA-5654693","FRS-mediated FGFR1 signaling","6/76","23/2914",1.8309453297408e-05,0.000166586009509204,0.000112479126382696,"FGF4/FGF17/FGF9/FGF5/FGF22/FGF20",6
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","15/76","171/2914",2.22428484953304e-05,0.000199109369595296,0.00013443894846074,"MAPK3/PPP2CA/FLT3LG/JAK2/ERBB2/NRG4/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",15
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","6/76","24/2914",2.39102528630523e-05,0.000207346724046782,0.000140000822684977,"STAT3/FGF4/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","6/76","24/2914",2.39102528630523e-05,0.000207346724046782,0.000140000822684977,"AKT1/ERBB2/AKT2/NRG4/AKT3/NRG1",6
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","11/76","95/2914",2.44882882891002e-05,0.00020909230769924,0.000141179443415703,"TP53/MAPK14/PPP2CA/AKT1/CSNK2A1/CDK1/EP300/CHEK1/STK11/AKT2/AKT3",11
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","6/76","25/2914",3.08135876764342e-05,0.000259114260006379,0.000174954341512131,"FGF4/FGF18/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","7/76","38/2914",4.09768262582588e-05,0.000339434904079607,0.000229186962261432,"MAPK3/PPP2CA/FGF4/FGF18/FGF17/FGF9/FGF20",7
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","6/76","28/2914",6.15872116345994e-05,0.000502660330252981,0.00033939701767674,"FGF4/FGF17/FGF9/FGF5/FGF22/FGF20",6
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","6/76","29/2914",7.60569941267813e-05,0.000603023310576624,0.000407162254272694,"TP53/PPP2CA/AKT1/CDK1/AKT2/AKT3",6
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","6/76","29/2914",7.60569941267813e-05,0.000603023310576624,0.000407162254272694,"TP53/PPP2CA/AKT1/CDK1/AKT2/AKT3",6
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","4/76","10/2914",7.97193539980452e-05,0.000623158330548099,0.000420757450308437,"TP53/AKT1/AKT2/AKT3",4
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","5/76","19/2914",9.23904848288373e-05,0.000702420809315133,0.000474275596237435,"FGF4/FGF18/FGF17/FGF9/FGF20",5
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","5/76","19/2914",9.23904848288373e-05,0.000702420809315133,0.000474275596237435,"FGF4/FGF18/FGF17/FGF9/FGF20",5
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","10/76","92/2914",0.000102845182075426,0.000771338865565693,0.000520809172387647,"RHOA/MAPK14/AKT1/ROCK2/AKT2/AKT3/MAPKAPK2/VEGFD/PAK1/VEGFC",10
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","23/76","397/2914",0.000106639973259926,0.000789135802123452,0.000532825690954858,"NOTCH1/RHOA/MAPK14/SMAD3/MAPK3/AKT1/ROCK2/CSNK2A1/EP300/MED1/ERBB2/STAT3/E2F1/SMAD4/NR2F2/CEBPE/AKT2/AKT3/EFNA5/MYO9B/EFNA4/PAK1/ARHGEF28",23
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","7/76","44/2914",0.00010972946119421,0.000801313828457715,0.000541048312813554,"RHOA/AKT1/ERBB2/AKT2/NRG4/AKT3/NRG1",7
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","6/76","31/2914",0.000113092298250097,0.000815145786088359,0.000550387671593088,"STAT3/FGF4/FGF17/FGF9/FGF5/FGF20",6
"R-HSA-69206","R-HSA-69206","G1/S Transition","8/76","60/2914",0.000126552629976521,0.000900470636371399,0.000607999139968171,"PPP2CA/AKT1/CDK1/MAX/E2F6/E2F1/AKT2/AKT3",8
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","9/76","77/2914",0.000133367848805528,0.000936951342874282,0.000632630968351341,"PPP2CA/AKT1/CDK1/MAX/JAK2/E2F6/E2F1/AKT2/AKT3",9
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","5/76","21/2914",0.000155203283840694,0.00106342990779735,0.000718029487294177,"RHOA/AKT1/AKT2/AKT3/PAK1",5
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","5/76","21/2914",0.000155203283840694,0.00106342990779735,0.000718029487294177,"FGF4/FGF18/FGF17/FGF9/FGF20",5
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","8/76","62/2914",0.000160345117535568,0.00108526268575903,0.000732771012100929,"MAPK3/AKT1/YAP1/CDK1/SMAD4/ZNF521/AKT2/AKT3",8
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","7/76","49/2914",0.000221528186308833,0.00146366837382622,0.000988271106841409,"TP53/MAPK3/AKT1/STAT3/E2F1/AKT2/AKT3",7
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","7/76","49/2914",0.000221528186308833,0.00146366837382622,0.000988271106841409,"SMAD3/AKT1/EP300/SMAD4/STK11/AKT2/AKT3",7
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","5/76","24/2914",0.000304905148788039,0.00199085126561602,0.00134422579527606,"NOTCH1/AKT1/EP300/AKT2/AKT3",5
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","14/76","191/2914",0.000309661453674083,0.00199839659057112,0.00134932041013432,"TP53/MAPK3/PPP2CA/AKT1/CSNK2A1/CDK1/MAX/EP300/JAK2/E2F6/E2F1/AKT2/PLK1/AKT3",14
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","4/76","14/2914",0.000350912499573703,0.00223857973865983,0.00151149243615533,"RHOA/ERBB2/NRG4/NRG1",4
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","5/76","25/2914",0.000373428039065939,0.00235514274638177,0.00159019595583103,"AKT1/CSNK2A1/AKT2/AKT3/PREX2",5
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","5/76","26/2914",0.000452998126261676,0.00282487595590146,0.00190736053162811,"FGF4/FGF18/FGF17/FGF9/FGF20",5
"R-HSA-1643685","R-HSA-1643685","Disease","23/76","443/2914",0.000567256782975446,0.00349808349501525,0.0023619112835001,"NOTCH1/SMAD3/MAPK3/PPP2CA/AKT1/EP300/JAK2/NR4A1/ERBB2/STAT3/SMAD4/AKT2/NRG4/AKT3/FGF4/FGF7/FGF18/FGF17/NRG1/FGF9/FGF5/FGF22/FGF20",23
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","4/76","16/2914",0.000613165423637119,0.00373963527602858,0.00252500741254846,"RHOA/AKT1/AKT2/AKT3",4
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","7/76","59/2914",0.000713732595241475,0.00430566946042411,0.00290719455269983,"TP53/MAPK3/AKT1/CSNK2A1/AKT2/AKT3/PREX2",7
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","5/76","29/2914",0.000769273363697934,0.00459082491239089,0.0030997319465361,"TP53/AKT1/E2F1/AKT2/AKT3",5
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","4/76","18/2914",0.000990810430828774,0.00584999775648904,0.00394992736142266,"MAX/E2F6/E2F1/CHEK1",4
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","6/76","47/2914",0.00118376965496757,0.00684366831778126,0.00462085523211025,"RHOA/AKT1/ERBB2/STAT3/NRG4/NRG1",6
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","6/76","47/2914",0.00118376965496757,0.00684366831778126,0.00462085523211025,"RHOA/AKT1/ERBB2/STAT3/NRG4/NRG1",6
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","4/76","19/2914",0.00123038908309542,0.00703985506307176,0.00475332082020587,"PPP2CA/AKT1/AKT2/AKT3",4
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","8/76","85/2914",0.0014073231511217,0.00797004437625043,0.00538138605584666,"RHOA/MAPK14/AKT1/ROCK2/AKT2/AKT3/MAPKAPK2/PAK1",8
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","15/76","249/2914",0.00150685485250803,0.00844751962769652,0.0057037780700995,"TP53/MAPK3/PPP2CA/AKT1/CSNK2A1/CDK1/MAX/EP300/JAK2/E2F6/E2F1/CHEK1/AKT2/PLK1/AKT3",15
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","3/76","10/2914",0.00179358592735423,0.00995440189681598,0.00672122726461164,"MAPK3/CDK1/JAK2",3
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","4/76","21/2914",0.00182607422544287,0.00995845479630158,0.00672396378849381,"RHOA/ROCK2/EFNA5/EFNA4",4
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","23/76","481/2914",0.00183020250310407,0.00995845479630158,0.00672396378849381,"TP53/NOTCH1/MAPK14/SMAD3/MAPK3/PPP2CA/AKT1/YAP1/CSNK2A1/CDK1/MAX/EP300/NR4A1/MED1/ERBB2/E2F6/E2F1/SMAD4/ZNF521/CHEK1/STK11/AKT2/AKT3",23
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","6/76","53/2914",0.00223569816418643,0.0120467231177036,0.00813396572764812,"TP53/NOTCH1/SMAD3/YAP1/EP300/SMAD4",6
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/76","11/2914",0.00242012986707161,0.0124367784835624,0.00839733170250967,"PPP2CA/CDK1/E2F1",3
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/76","11/2914",0.00242012986707161,0.0124367784835624,0.00839733170250967,"AKT1/AKT2/AKT3",3
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","3/76","11/2914",0.00242012986707161,0.0124367784835624,0.00839733170250967,"RHOA/ROCK2/ERBB2",3
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","3/76","11/2914",0.00242012986707161,0.0124367784835624,0.00839733170250967,"RHOA/ROCK2/PAK1",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/76","11/2914",0.00242012986707161,0.0124367784835624,0.00839733170250967,"AKT1/AKT2/AKT3",3
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","4/76","23/2914",0.0025969323814632,0.0132229125845145,0.00892813064027908,"TP53/NOTCH1/EP300/E2F1",4
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","23/76","499/2914",0.0030112086206887,0.0147453260394697,0.00995606651503312,"TP53/NOTCH1/MAPK14/SMAD3/MAPK3/PPP2CA/AKT1/YAP1/CSNK2A1/CDK1/MAX/EP300/NR4A1/MED1/ERBB2/E2F6/E2F1/SMAD4/ZNF521/CHEK1/STK11/AKT2/AKT3",23
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","5/76","39/2914",0.00304309145981476,0.0147453260394697,0.00995606651503312,"AKT1/MAX/E2F1/AKT2/AKT3",5
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/76","24/2914",0.00305533782799822,0.0147453260394697,0.00995606651503312,"MAPK14/MAPK3/PPP2CA/MAPKAPK2",4
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","4/76","24/2914",0.00305533782799822,0.0147453260394697,0.00995606651503312,"AKT1/NR4A1/AKT2/AKT3",4
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","4/76","24/2914",0.00305533782799822,0.0147453260394697,0.00995606651503312,"MAPK3/YAP1/SMAD4/ZNF521",4
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","4/76","24/2914",0.00305533782799822,0.0147453260394697,0.00995606651503312,"MAPK3/AKT1/AKT2/AKT3",4
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","5/76","40/2914",0.00340793756194497,0.0163052185075815,0.0110093082763377,"AKT1/MAX/E2F1/AKT2/AKT3",5
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","4/76","25/2914",0.00356617778779486,0.0169164843780013,0.0114220359195229,"AKT1/AKT2/AKT3/PAK1",4
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","12/76","194/2914",0.00380005590785222,0.0178731443123558,0.0120679741587457,"TP53/MAPK14/PPP2CA/AKT1/CSNK2A1/CDK1/EP300/E2F1/CHEK1/STK11/AKT2/AKT3",12
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","3/76","13/2914",0.00403993809364212,0.0185302945617469,0.0125116830042331,"AKT1/AKT2/AKT3",3
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","3/76","13/2914",0.00403993809364212,0.0185302945617469,0.0125116830042331,"ERBB2/NRG4/NRG1",3
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/76","13/2914",0.00403993809364212,0.0185302945617469,0.0125116830042331,"AKT1/AKT2/AKT3",3
"R-HSA-109581","R-HSA-109581","Apoptosis","8/76","101/2914",0.00422373701774348,0.0192145413512101,0.0129736874746909,"TP53/MAPK3/AKT1/STAT3/E2F1/AKT2/AKT3/ARHGAP10",8
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","6/76","61/2914",0.00458440130948632,0.020685713225731,0.0139670249565865,"RHOA/ROCK2/ARHGEF10/ARHGEF1/ARHGEF2/ARHGEF5",6
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/76","27/2914",0.00475612120347291,0.0211565222137895,0.0142849158996853,"EP300/STAT3/E2F1/CEBPE",4
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","8/76","103/2914",0.00476498248058323,0.0211565222137895,0.0142849158996853,"TP53/MAPK3/AKT1/STAT3/E2F1/AKT2/AKT3/ARHGAP10",8
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","5/76","44/2914",0.00518644992772097,0.0228450770625804,0.0154250306956446,"TP53/MAPK14/MAPK3/E2F1/MAPKAPK2",5
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","4/76","29/2914",0.00618791465251244,0.0262259528669816,0.0177078031686021,"TP53/NOTCH1/EP300/E2F1",4
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","3/76","15/2914",0.00619026995599024,0.0262259528669816,0.0177078031686021,"AKT1/AKT2/AKT3",3
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","3/76","15/2914",0.00619026995599024,0.0262259528669816,0.0177078031686021,"RHOA/ROCK2/ERBB2",3
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/76","15/2914",0.00619026995599024,0.0262259528669816,0.0177078031686021,"TP53/CDK1/EP300",3
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","3/76","15/2914",0.00619026995599024,0.0262259528669816,0.0177078031686021,"CDK1/E2F6/E2F1",3
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","4/76","30/2914",0.00700074696529395,0.0292136433514146,0.0197250963169343,"MAPK14/MAPK3/PPP2CA/MAPKAPK2",4
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/76","30/2914",0.00700074696529395,0.0292136433514146,0.0197250963169343,"TP53/CDK1/EP300/E2F1",4
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","3/76","16/2914",0.00747729407884096,0.0305139574540936,0.0206030703720386,"ERBB2/NRG4/NRG1",3
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","3/76","16/2914",0.00747729407884096,0.0305139574540936,0.0206030703720386,"ERBB2/NRG4/NRG1",3
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","3/76","16/2914",0.00747729407884096,0.0305139574540936,0.0206030703720386,"TP53/CDK1/PLK1",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","7/76","89/2914",0.00771037193261909,0.0312354483401722,0.0210902221130418,"RHOA/MAPK14/MAPK3/PPP2CA/STAT3/MAPKAPK2/NTF4",7
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","6/76","68/2914",0.00782380070303833,0.0312389164761603,0.0210925638037232,"RHOA/ROCK2/EFNA5/EFNA4/PAK1/ARHGEF28",6
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/76","68/2914",0.00782380070303833,0.0312389164761603,0.0210925638037232,"TP53/PPP2CA/CDK1/EP300/E2F1/PLK1",6
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","4/76","31/2914",0.00788134661991777,0.031243909814674,0.0210959353134641,"AKT1/AKT2/AKT3/PAK1",4
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/76","17/2914",0.0089111275194614,0.035075714704263,0.0236831757889381,"NOTCH1/SMAD3/EP300",3
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","6/76","70/2914",0.00899460714692051,0.0351549786376119,0.023736694917003,"RHOA/MAPK14/MAPK3/PPP2CA/STAT3/MAPKAPK2",6
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","4/76","33/2914",0.00985468187500903,0.0382471918925176,0.0258245619985514,"MAPK3/PPP2CA/CDK1/PLK1",4
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/76","18/2914",0.0104951909371879,0.0404502150704118,0.0273120465909276,"PPP2CA/CDK1/PLK1",3
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","4/76","34/2914",0.0109515738684168,0.041918093082561,0.028303160051952,"RHOA/ROCK2/PAK1/ARHGEF28",4
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","5/76","53/2914",0.0114248548439291,0.0434300988930183,0.0293240686693495,"PPP2CA/AKT1/AKT2/AKT3/PAK1",5
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","4/76","35/2914",0.0121245406291094,0.0455634188797369,0.0307644895612827,"TP53/AKT1/AKT2/AKT3",4
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","3/76","19/2914",0.0122323412848303,0.0455634188797369,0.0307644895612827,"CDK1/MAX/E2F1",3
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/76","19/2914",0.0122323412848303,0.0455634188797369,0.0307644895612827,"MAPK3/YAP1/ZNF521",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/76","20/2914",0.0141249050832634,0.0522621488080746,0.0352874821729247,"MAPK3/CSNK2A1/PAK1",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/76","56/2914",0.0143150651761102,0.0526149746539149,0.0355257107193812,"TP53/MAPK14/CSNK2A1/CHEK1/STK11",5
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","4/76","38/2914",0.0161173931075543,0.0579158979068362,0.0391049021428804,"RHOA/ROCK2/ERBB2/PAK1",4
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","3/76","21/2914",0.0161747102262335,0.0579158979068362,0.0391049021428804,"MAPK14/MAPK3/PPP2CA",3
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","3/76","21/2914",0.0161747102262335,0.0579158979068362,0.0391049021428804,"AKT1/AKT2/AKT3",3
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","3/76","21/2914",0.0161747102262335,0.0579158979068362,0.0391049021428804,"MAPK14/MAP3K7/MAPKAPK2",3
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","3/76","22/2914",0.018383116371133,0.0654014717049923,0.0441591729293073,"ERBB2/NRG4/NRG1",3
"R-HSA-450294","R-HSA-450294","MAP kinase activation","5/76","60/2914",0.0188844241143119,0.0667570406588733,0.0450744551437817,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","4/76","40/2914",0.0191897836155096,0.0674071513076444,0.0455134108402492,"NOTCH1/SMAD3/AKT1/EP300",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/76","23/2914",0.0207510439695834,0.0719801837694925,0.0486011292971822,"MAPK3/CDK1/JAK2",3
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/76","23/2914",0.0207510439695834,0.0719801837694925,0.0486011292971822,"TP53/MAPK3/E2F1",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/76","24/2914",0.0232790019898099,0.0802474913313323,0.0541832279069783,"MAPK3/JAK2/STAT3",3
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","5/76","64/2914",0.024328449162204,0.0833474647223654,0.0562763346442145,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/76","25/2914",0.0259671143809938,0.0871521856947981,0.0588452880177299,"AKT1/AKT2/AKT3",3
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/76","10/2914",0.0263812021562632,0.0871521856947981,0.0588452880177299,"PPP2CA/E2F1",2
"R-HSA-1250342","R-HSA-1250342","PI3K events in ERBB4 signaling","2/76","10/2914",0.0263812021562632,0.0871521856947981,0.0588452880177299,"NRG4/NRG1",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/76","10/2914",0.0263812021562632,0.0871521856947981,0.0588452880177299,"CDK1/E2F1",2
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","2/76","10/2914",0.0263812021562632,0.0871521856947981,0.0588452880177299,"MAPK14/MAPK3",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/76","10/2914",0.0263812021562632,0.0871521856947981,0.0588452880177299,"JAK2/STAT3",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","5/76","66/2914",0.0273951676708912,0.0899663790375422,0.0607454356327455,"TP53/PPP2CA/CDK1/EP300/PLK1",5
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/76","11/2914",0.0317058848871946,0.0986676003112463,0.0666205134391725,"JAK2/STAT3",2
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/76","11/2914",0.0317058848871946,0.0986676003112463,0.0666205134391725,"MAX/E2F1",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/76","11/2914",0.0317058848871946,0.0986676003112463,0.0666205134391725,"JAK2/STAT3",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/76","11/2914",0.0317058848871946,0.0986676003112463,0.0666205134391725,"STAT3/SMAD4",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/76","11/2914",0.0317058848871946,0.0986676003112463,0.0666205134391725,"TP53/E2F1",2
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","2/76","11/2914",0.0317058848871946,0.0986676003112463,0.0666205134391725,"CDK1/CHEK1",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/76","11/2914",0.0317058848871946,0.0986676003112463,0.0666205134391725,"JAK2/STAT3",2
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","3/76","27/2914",0.0318225233436272,0.0986676003112463,0.0666205134391725,"YAP1/NRG4/NRG1",3
"R-HSA-165159","R-HSA-165159","mTOR signalling","3/76","27/2914",0.0318225233436272,0.0986676003112463,0.0666205134391725,"AKT1/STK11/AKT2",3
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","3/76","27/2914",0.0318225233436272,0.0986676003112463,0.0666205134391725,"TP53/RHOA/CDK1",3
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","4/76","48/2914",0.0349635044614154,0.107804138756031,0.0727895180600228,"ARHGEF10/ARHGEF1/ARHGEF2/ARHGEF5",4
"R-HSA-69242","R-HSA-69242","S Phase","5/76","71/2914",0.0361106076622972,0.110725896423066,0.0747622932700075,"AKT1/MAX/E2F1/AKT2/AKT3",5
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/76","12/2914",0.0374137320075479,0.112851202522767,0.076197303173267,"SMAD3/SMAD4",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/76","12/2914",0.0374137320075479,0.112851202522767,0.076197303173267,"MAPK3/PPP2CA",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/76","12/2914",0.0374137320075479,0.112851202522767,0.076197303173267,"NOTCH1/EP300",2
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","7/76","124/2914",0.040787745379656,0.122363236138968,0.0826198427035992,"TP53/RHOA/SMAD3/CDK1/MAP3K7/EP300/SMAD4",7
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/76","30/2914",0.0417904648274187,0.124697354726975,0.0841958431157955,"TP53/CSNK2A1/STAT3",3
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","6/76","99/2914",0.0424737373971678,0.125689273272024,0.0848655880224575,"TP53/MAPK14/MAPK3/STAT3/E2F1/MAPKAPK2",6
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","2/76","13/2914",0.043481694537349,0.125689273272024,0.0848655880224575,"EP300/MED1",2
"R-HSA-171007","R-HSA-171007","p38MAPK events","2/76","13/2914",0.043481694537349,0.125689273272024,0.0848655880224575,"MAPK14/MAPKAPK2",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/76","13/2914",0.043481694537349,0.125689273272024,0.0848655880224575,"TP53/EP300",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/76","13/2914",0.043481694537349,0.125689273272024,0.0848655880224575,"NOTCH1/EP300",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/76","13/2914",0.043481694537349,0.125689273272024,0.0848655880224575,"EP300/STK11",2
"R-HSA-391251","R-HSA-391251","Protein folding","3/76","31/2914",0.0454235846353652,0.129948914807359,0.0877417044502985,"TP53/CSNK2A1/STAT3",3
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","3/76","31/2914",0.0454235846353652,0.129948914807359,0.0877417044502985,"MAPK14/AKT1/MAPKAPK2",3
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","5/76","76/2914",0.0463735972677772,0.131986392223674,0.0891174122932722,"RHOA/ARHGEF10/ARHGEF1/ARHGEF2/ARHGEF5",5
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","3/76","32/2914",0.0492089263707488,0.139133863741267,0.0939433959068584,"JAK2/STAT3/AIP",3
"R-HSA-1250347","R-HSA-1250347","SHC1 events in ERBB4 signaling","2/76","14/2914",0.0498876376297516,0.139133863741267,0.0939433959068584,"NRG4/NRG1",2
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/76","14/2914",0.0498876376297516,0.139133863741267,0.0939433959068584,"MAPK3/PPP2CA",2
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","2/76","14/2914",0.0498876376297516,0.139133863741267,0.0939433959068584,"SMAD3/SMAD4",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","7/76","130/2914",0.0505821898127555,0.139218923099111,0.0940008281143356,"RHOA/MAPK14/MAPK3/PPP2CA/ROCK2/PLK1/PAK1",7
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","5/76","78/2914",0.0509215160164315,0.139218923099111,0.0940008281143356,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","5/76","78/2914",0.0509215160164315,0.139218923099111,0.0940008281143356,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","5/76","78/2914",0.0509215160164315,0.139218923099111,0.0940008281143356,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","6/76","104/2914",0.0519593082534,0.141359882748221,0.0954464073179072,"TP53/NOTCH1/SMAD3/AKT1/EP300/E2F1",6
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/76","33/2914",0.0531443508203229,0.143878608318435,0.0971470546445954,"MAPK14/MAPK3/MAPKAPK2",3
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","6/76","106/2914",0.0560916675784165,0.14890389486567,0.10054013574619,"RHOA/MAP3K7/ARHGEF10/ARHGEF1/ARHGEF2/ARHGEF5",6
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","4/76","56/2914",0.0565335308646441,0.14890389486567,0.10054013574619,"PPP2CA/CSNK2A1/CDK1/PLK1",4
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/76","15/2914",0.056610309579561,0.14890389486567,0.10054013574619,"SMAD3/SMAD4",2
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","2/76","15/2914",0.056610309579561,0.14890389486567,0.10054013574619,"CDK1/PLK1",2
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","2/76","15/2914",0.056610309579561,0.14890389486567,0.10054013574619,"MAPK14/PPP2CA",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/76","15/2914",0.056610309579561,0.14890389486567,0.10054013574619,"SMAD3/STAT3",2
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","3/76","34/2914",0.0572275227834106,0.149817335588646,0.101156892308313,"PPP2CA/CDK1/PLK1",3
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","6/76","108/2914",0.060419189884857,0.157430283502797,0.106297166291125,"MAPK3/AKT1/EP300/MED1/AKT2/AKT3",6
"R-HSA-422475","R-HSA-422475","Axon guidance","11/76","254/2914",0.0623766266370294,0.161771157867062,0.109228131248315,"RHOA/MAPK14/MAPK3/ROCK2/CSNK2A1/ERBB2/EFNA5/MYO9B/EFNA4/PAK1/ARHGEF28",11
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","5/76","83/2914",0.063408251445544,0.163491981692787,0.110390034106462,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/76","16/2914",0.0636293117939496,0.163491981692787,0.110390034106462,"MAPK14/MAPK3",2
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","5/76","84/2914",0.0660970888131002,0.16827469858381,0.11361933180813,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","5/76","84/2914",0.0660970888131002,0.16827469858381,0.11361933180813,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","5/76","86/2914",0.0716654178098331,0.179974239296187,0.121518879448919,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","5/76","86/2914",0.0716654178098331,0.179974239296187,0.121518879448919,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","5/76","86/2914",0.0716654178098331,0.179974239296187,0.121518879448919,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","4/76","61/2914",0.0729568831180608,0.182392207795152,0.12315149544822,"ARHGEF10/ARHGEF1/ARHGEF2/ARHGEF5",4
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","5/76","87/2914",0.0745445146978807,0.183876469588106,0.124153671262903,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","5/76","87/2914",0.0745445146978807,0.183876469588106,0.124153671262903,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","5/76","87/2914",0.0745445146978807,0.183876469588106,0.124153671262903,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-195721","R-HSA-195721","Signaling by WNT","8/76","172/2914",0.0764793085107727,0.18781423107734,0.126812453795226,"RHOA/PPP2CA/AKT1/CSNK2A1/NLK/MAP3K7/EP300/AKT2",8
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/76","18/2914",0.0784788045422181,0.191033932109347,0.128986400817311,"CSNK2A1/EP300",2
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","2/76","18/2914",0.0784788045422181,0.191033932109347,0.128986400817311,"NOTCH1/EP300",2
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","4/76","63/2914",0.0801415782206921,0.194229589137485,0.131144113291503,"MAPK3/AKT1/AKT2/AKT3",4
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","5/76","90/2914",0.0835583334601371,0.200757034936693,0.135551454599265,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","5/76","90/2914",0.0835583334601371,0.200757034936693,0.135551454599265,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","3/76","40/2914",0.0846777253290794,0.200838194690765,0.135606253788359,"EP300/MED1/NR2F2",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","3/76","40/2914",0.0846777253290794,0.200838194690765,0.135606253788359,"PPP2CA/JAK2/E2F1",3
"R-HSA-69236","R-HSA-69236","G1 Phase","3/76","40/2914",0.0846777253290794,0.200838194690765,0.135606253788359,"PPP2CA/JAK2/E2F1",3
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","2/76","19/2914",0.0862725061019108,0.202030552263968,0.136411335430958,"CDK1/PLK1",2
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/76","19/2914",0.0862725061019108,0.202030552263968,0.136411335430958,"EP300/PAK1",2
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","2/76","19/2914",0.0862725061019108,0.202030552263968,0.136411335430958,"SMAD3/SMAD4",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","3/76","41/2914",0.0897165047143039,0.209212857632095,0.141260838913278,"JAK2/STAT3/CHEK1",3
"R-HSA-167044","R-HSA-167044","Signalling to RAS","2/76","20/2914",0.0942889062150937,0.218043095622404,0.147223029002515,"MAPK14/MAPKAPK2",2
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/76","20/2914",0.0942889062150937,0.218043095622404,0.147223029002515,"SMAD3/SMAD4",2
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","5/76","94/2914",0.0964418164815783,0.22209629936629,0.14995975832034,"TP53/AKT1/JAK2/STAT3/STAT6",5
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/76","43/2914",0.100162015983761,0.229710408557798,0.155100816399386,"MAPK3/MYO9B/PAK1",3
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","3/76","44/2914",0.105561768772447,0.241097866949416,0.162789645583674,"YAP1/NRG4/NRG1",3
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","3/76","46/2914",0.116697383863995,0.265438721493922,0.179224627504668,"TP53/CDK1/CHEK1",3
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/76","23/2914",0.119512214732755,0.269631216165362,0.182055406268125,"JAK2/STAT3",2
"R-HSA-9020591","R-HSA-9020591","Interleukin-12 signaling","2/76","23/2914",0.119512214732755,0.269631216165362,0.182055406268125,"JAK2/AIP",2
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","3/76","47/2914",0.122425955266014,0.275086660617966,0.185738930640106,"RHOA/PPP2CA/PLK1",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","2/76","24/2914",0.128260688618477,0.283604311487071,0.191490061430815,"SMAD3/SMAD4",2
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","2/76","24/2914",0.128260688618477,0.283604311487071,0.191490061430815,"RHOA/PAK1",2
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","2/76","24/2914",0.128260688618477,0.283604311487071,0.191490061430815,"TP53/CHEK1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/76","24/2914",0.128260688618477,0.283604311487071,0.191490061430815,"JAK2/STAT3",2
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","3/76","49/2914",0.134186155145128,0.294360933223501,0.198752948748348,"STAT3/STAT6/PDGFD",3
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/76","49/2914",0.134186155145128,0.294360933223501,0.198752948748348,"MAPK3/EP300/MAPKAPK2",3
"R-HSA-68886","R-HSA-68886","M Phase","5/76","105/2914",0.136708894498021,0.296192447575447,0.199989590017751,"MAPK3/PPP2CA/CSNK2A1/CDK1/PLK1",5
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/76","25/2914",0.137155782030432,0.296192447575447,0.199989590017751,"CDK1/PLK1",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/76","25/2914",0.137155782030432,0.296192447575447,0.199989590017751,"CDK1/PLK1",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/76","25/2914",0.137155782030432,0.296192447575447,0.199989590017751,"EP300/ERBB2",2
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","6/76","136/2914",0.141229360855899,0.303807346027224,0.205131181006528,"MAPK3/AKT1/EP300/MED1/AKT2/AKT3",6
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/76","26/2914",0.146184168422297,0.310851392622126,0.209887331955385,"AKT1/AKT2",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/76","26/2914",0.146184168422297,0.310851392622126,0.209887331955385,"CDK1/PLK1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/76","26/2914",0.146184168422297,0.310851392622126,0.209887331955385,"CDK1/PLK1",2
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","5/76","108/2914",0.148835799519367,0.315192011420711,0.21281812435424,"PPP2CA/AKT1/CSNK2A1/EP300/AKT2",5
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","12/76","332/2914",0.149361259466031,0.315192011420711,0.21281812435424,"TP53/MAPK14/SMAD3/MAPK3/PPP2CA/AKT1/MAP3K7/JAK2/STAT3/AIP/STAT6/MAPKAPK2",12
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","4/76","80/2914",0.154023276313348,0.322577050392106,0.217804513873096,"MAPK14/CDK1/MED1/PLK1",4
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/76","80/2914",0.154023276313348,0.322577050392106,0.217804513873096,"TP53/SMAD3/MAP3K7/SMAD4",4
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/76","27/2914",0.155333100028591,0.322883410171789,0.21801136846118,"CDK1/PLK1",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/76","27/2914",0.155333100028591,0.322883410171789,0.21801136846118,"CDK1/PLK1",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","5/76","110/2914",0.157171250440514,0.325485238785393,0.219768127088857,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/76","53/2914",0.158814226796976,0.327665040417553,0.22123993245832,"MAPK3/CSNK2A1/PAK1",3
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/76","28/2914",0.164590387396761,0.337076254631743,0.22759439857544,"SMAD3/SMAD4",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/76","28/2914",0.164590387396761,0.337076254631743,0.22759439857544,"CDK1/PLK1",2
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","2/76","29/2914",0.173944379571247,0.350717651965904,0.236805090753649,"PPP2CA/PLK1",2
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2/76","29/2914",0.173944379571247,0.350717651965904,0.236805090753649,"PPP2CA/PLK1",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/76","29/2914",0.173944379571247,0.350717651965904,0.236805090753649,"STAT3/STAT6",2
"R-HSA-5673000","R-HSA-5673000","RAF activation","2/76","29/2914",0.173944379571247,0.350717651965904,0.236805090753649,"PPP2CA/JAK2",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","5/76","114/2914",0.174410940437098,0.350717651965904,0.236805090753649,"TP53/PPP2CA/CDK1/CHEK1/PLK1",5
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","2/76","30/2914",0.183383944910091,0.366108235342089,0.247196836001486,"CDK1/PLK1",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/76","30/2914",0.183383944910091,0.366108235342089,0.247196836001486,"MAPK3/PAK1",2
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","2/76","31/2914",0.192898452515245,0.383722728121724,0.259090168252885,"AKT1/AKT2",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","2/76","32/2914",0.202477754258212,0.399911578695044,0.270020904723444,"MAPK3/MAPKAPK2",2
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","2/76","32/2914",0.202477754258212,0.399911578695044,0.270020904723444,"TP53/MAPK3",2
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","6/76","153/2914",0.20679192124269,0.40698410031806,0.274796282054489,"RHOA/MAPK14/MAPK3/AKT1/VEGFD/VEGFC",6
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/76","33/2914",0.212112167383236,0.414983994322675,0.280197822624699,"MAPK14/MAP3K7",2
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","7/76","187/2914",0.21235217006782,0.414983994322675,0.280197822624699,"TP53/MAPK14/MAPK3/EP300/STAT3/E2F1/MAPKAPK2",7
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/76","62/2914",0.218539691676443,0.421557582216619,0.284636319144839,"MAPK3/MYO9B/PAK1",3
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","3/76","62/2914",0.218539691676443,0.421557582216619,0.284636319144839,"TP53/CDK1/CHEK1",3
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","7/76","189/2914",0.220022019162051,0.421557582216619,0.284636319144839,"TP53/MAPK14/MAPK3/EP300/STAT3/E2F1/MAPKAPK2",7
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/76","34/2914",0.221792457670726,0.421557582216619,0.284636319144839,"CDK1/PLK1",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","2/76","34/2914",0.221792457670726,0.421557582216619,0.284636319144839,"EP300/STAT6",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/76","34/2914",0.221792457670726,0.421557582216619,0.284636319144839,"MAPK3/PPP2CA",2
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","2/76","34/2914",0.221792457670726,0.421557582216619,0.284636319144839,"CDK1/PAK1",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/76","34/2914",0.221792457670726,0.421557582216619,0.284636319144839,"TP53/CHEK1",2
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/76","63/2914",0.225459597349231,0.42456206977418,0.286664953702433,"RHOA/SMAD3/SMAD4",3
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","2/76","35/2914",0.23150982314408,0.42456206977418,0.286664953702433,"MAPK14/PAK1",2
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","3/76","64/2914",0.232423391309459,0.42456206977418,0.286664953702433,"RHOA/MYO9B/PAK1",3
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"MAPK3",1
"R-HSA-169911","R-HSA-169911","Regulation of Apoptosis","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"ARHGAP10",1
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"AIP",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"EP300",1
"R-HSA-74749","R-HSA-74749","Signal attenuation","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"MAPK3",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"CSNK2A1",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"STAT3",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"EP300",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/76","10/2914",0.232552917497929,0.42456206977418,0.286664953702433,"MAPK3",1
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","5/76","127/2914",0.234972880025727,0.42757360135829,0.288698344397442,"MAPK14/MAPK3/PPP2CA/MAP3K7/MAPKAPK2",5
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","2/76","36/2914",0.241255878303619,0.436803362994538,0.294930293458616,"SMAD3/SMAD4",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/76","37/2914",0.251022638871716,0.436803362994538,0.294930293458616,"CDK1/PLK1",2
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","2/76","37/2914",0.251022638871716,0.436803362994538,0.294930293458616,"NOTCH1/EP300",2
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"STAT6",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"EP300",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"TP53",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"TP53",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"CHEK1",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"CHEK1",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"CHEK1",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"ERBB2",1
"R-HSA-8963889","R-HSA-8963889","Assembly of active LPL and LIPC lipase complexes","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"FGF21",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"MAPKAPK2",1
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"JAK2",1
"R-HSA-9028731","R-HSA-9028731","Activated NTRK2 signals through FRS2 and FRS3","1/76","11/2914",0.252637620759003,0.436803362994538,0.294930293458616,"NTF4",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/76","38/2914",0.260802507033748,0.449519849079907,0.303516484158268,"MAPK14/MED1",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"MAPK3",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"CSNK2A1",1
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"MAPK3",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"STAT3",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"YAP1",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"NOTCH1",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"CDK1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"PAK1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"PAK1",1
"R-HSA-425407","R-HSA-425407","SLC-mediated transmembrane transport","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"FGF21",1
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","1/76","12/2914",0.272203428827317,0.452314080835811,0.305403153679562,"MAP3K7",1
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/76","40/2914",0.280373021993065,0.452516260335322,0.3055396655844,"CDK1/PLK1",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/76","40/2914",0.280373021993065,0.452516260335322,0.3055396655844,"NOTCH1/EP300",2
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","2/76","40/2914",0.280373021993065,0.452516260335322,0.3055396655844,"NLK/MAP3K7",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/76","40/2914",0.280373021993065,0.452516260335322,0.3055396655844,"CDK1/PLK1",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","3/76","72/2914",0.289319881343655,0.452516260335322,0.3055396655844,"MAP3K7/EP300/PAK1",3
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/76","41/2914",0.290150279289412,0.452516260335322,0.3055396655844,"JAK2/STAT3",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"MAPK3",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"NOTCH1",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"PAK1",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"EP300",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"PAK1",1
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","1/76","13/2914",0.291263573351481,0.452516260335322,0.3055396655844,"MAP3K7",1
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","2/76","42/2914",0.299913838896716,0.452516260335322,0.3055396655844,"EFNA5/EFNA4",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","2/76","42/2914",0.299913838896716,0.452516260335322,0.3055396655844,"MAPK14/PPP2CA",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/76","42/2914",0.299913838896716,0.452516260335322,0.3055396655844,"CDK1/PLK1",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/76","42/2914",0.299913838896716,0.452516260335322,0.3055396655844,"MAPK3/JAK2",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/76","42/2914",0.299913838896716,0.452516260335322,0.3055396655844,"MAPK3/JAK2",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/76","42/2914",0.299913838896716,0.452516260335322,0.3055396655844,"MAPK3/JAK2",2
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","2/76","42/2914",0.299913838896716,0.452516260335322,0.3055396655844,"PPP2CA/PLK1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/76","42/2914",0.299913838896716,0.452516260335322,0.3055396655844,"MAPK3/JAK2",2
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"AIP",1
"R-HSA-2173791","R-HSA-2173791","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"RHOA",1
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"MED1",1
"R-HSA-3214858","R-HSA-3214858","RMTs methylate histone arginines","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"JAK2",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PAK1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"JAK2",1
"R-HSA-8849471","R-HSA-8849471","PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"RHOA",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"STAT3",1
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"JAK2",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"EP300",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"NRG1",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/76","14/2914",0.309830953022383,0.452516260335322,0.3055396655844,"PPP2CA",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","4/76","109/2914",0.316300555260713,0.460752777348283,0.311100974368874,"MAPK14/PPP2CA/AKT1/MAPKAPK2",4
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","3/76","76/2914",0.318238033661675,0.462361541052958,0.312187214063258,"RHOA/NLK/MAP3K7",3
"R-HSA-1170546","R-HSA-1170546","Prolactin receptor signaling","1/76","15/2914",0.327918141839728,0.469058166806827,0.316708785933106,"JAK2",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/76","15/2914",0.327918141839728,0.469058166806827,0.316708785933106,"YAP1",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/76","15/2914",0.327918141839728,0.469058166806827,0.316708785933106,"EP300",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/76","15/2914",0.327918141839728,0.469058166806827,0.316708785933106,"TP53",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/76","15/2914",0.327918141839728,0.469058166806827,0.316708785933106,"TP53",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/76","15/2914",0.327918141839728,0.469058166806827,0.316708785933106,"AKT1",1
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","2/76","45/2914",0.329065151890904,0.469488841386765,0.316999578062946,"MAPK3/STAT3",2
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/76","46/2914",0.338718232255763,0.475864157401346,0.321304201109301,"NR4A1/MED1",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/76","46/2914",0.338718232255763,0.475864157401346,0.321304201109301,"MAPK3/JAK2",2
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","13/76","436/2914",0.345056609424547,0.475864157401346,0.321304201109301,"RHOA/MAPK3/PPP2CA/AKT1/ROCK2/AKT2/AKT3/PAK1/ARHGEF10/ARHGEF1/ARHGEF2/ARHGEF5/ARHGEF25",13
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"MAPK3",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"CHEK1",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"PPP2CA",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"TP53",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"PAK1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"CSNK2A1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"PAK1",1
"R-HSA-6788467","R-HSA-6788467","IL-6-type cytokine receptor ligand interactions","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"JAK2",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"EP300",1
"R-HSA-8950505","R-HSA-8950505","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"AIP",1
"R-HSA-8963899","R-HSA-8963899","Plasma lipoprotein remodeling","1/76","16/2914",0.345537397176113,0.475864157401346,0.321304201109301,"FGF21",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/76","47/2914",0.348331222344197,0.477342786175381,0.322302573501063,"EP300/MED1",2
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","2/76","47/2914",0.348331222344197,0.477342786175381,0.322302573501063,"MAPK3/NRG1",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","2/76","48/2914",0.357899676127872,0.488045012901644,0.329528733225197,"MAPK14/MAP3K7",2
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/76","48/2914",0.357899676127872,0.488045012901644,0.329528733225197,"EP300/MED1",2
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","3/76","82/2914",0.361699189980952,0.490972854980895,0.331505616639542,"SMAD3/MAP3K7/STAT3",3
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/76","17/2914",0.362700667643544,0.490972854980895,0.331505616639542,"CDK1",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/76","17/2914",0.362700667643544,0.490972854980895,0.331505616639542,"MAPK14",1
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","2/76","49/2914",0.36741940042501,0.493747620425861,0.333379142478154,"MAPK3/NRG1",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/76","49/2914",0.36741940042501,0.493747620425861,0.333379142478154,"MAPK3/JAK2",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/76","49/2914",0.36741940042501,0.493747620425861,0.333379142478154,"EP300/MED1",2
"R-HSA-109582","R-HSA-109582","Hemostasis","9/76","298/2914",0.373134092482613,0.500215993545532,0.337746597823062,"TP53/RHOA/MAPK14/MAPK3/PPP2CA/AKT1/JAK2/VEGFD/VEGFC",9
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","4/76","119/2914",0.376609601223969,0.503658623323622,0.340071066672754,"CSNK2A1/EP300/MED1/MAPKAPK2",4
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/76","18/2914",0.379419600767151,0.503774828769782,0.34014952876632,"PAK1",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/76","18/2914",0.379419600767151,0.503774828769782,0.34014952876632,"STK11",1
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","1/76","18/2914",0.379419600767151,0.503774828769782,0.34014952876632,"MAPK3",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/76","51/2914",0.386297093221354,0.506843703871989,0.342221637891755,"NOTCH1/EP300",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/76","51/2914",0.386297093221354,0.506843703871989,0.342221637891755,"NOTCH1/EP300",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/76","51/2914",0.386297093221354,0.506843703871989,0.342221637891755,"NOTCH1/EP300",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/76","51/2914",0.386297093221354,0.506843703871989,0.342221637891755,"NOTCH1/EP300",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/76","51/2914",0.386297093221354,0.506843703871989,0.342221637891755,"NOTCH1/EP300",2
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","3/76","86/2914",0.390500702161245,0.509947975763508,0.344317646983042,"YAP1/CSNK2A1/EP300",3
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/76","86/2914",0.390500702161245,0.509947975763508,0.344317646983042,"RHOA/SMAD3/SMAD4",3
"R-HSA-400253","R-HSA-400253","Circadian Clock","2/76","52/2914",0.395647852473739,0.510736233747164,0.344849879969636,"EP300/MED1",2
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","1/76","19/2914",0.395705550470776,0.510736233747164,0.344849879969636,"MED1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/76","19/2914",0.395705550470776,0.510736233747164,0.344849879969636,"EP300",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/76","19/2914",0.395705550470776,0.510736233747164,0.344849879969636,"CSNK2A1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/76","19/2914",0.395705550470776,0.510736233747164,0.344849879969636,"EP300",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/76","87/2914",0.397659261142647,0.512067030009672,0.345748435625308,"MAPK3/MAP3K7/PAK1",3
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/76","20/2914",0.411569584378969,0.521509404863763,0.352123941453769,"MED1",1
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/76","20/2914",0.411569584378969,0.521509404863763,0.352123941453769,"MAP3K7",1
"R-HSA-70171","R-HSA-70171","Glycolysis","1/76","20/2914",0.411569584378969,0.521509404863763,0.352123941453769,"PPP2CA",1
"R-HSA-70326","R-HSA-70326","Glucose metabolism","1/76","20/2914",0.411569584378969,0.521509404863763,0.352123941453769,"PPP2CA",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/76","20/2914",0.411569584378969,0.521509404863763,0.352123941453769,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/76","20/2914",0.411569584378969,0.521509404863763,0.352123941453769,"MAPK3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/76","20/2914",0.411569584378969,0.521509404863763,0.352123941453769,"EP300",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/76","55/2914",0.42330905050292,0.535162922617587,0.361342817357726,"PPP2CA/STK11",2
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/76","21/2914",0.427022490939853,0.538630641980952,0.363684226733464,"NOTCH1",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","2/76","56/2914",0.432389508692398,0.544016643984716,0.367320863458623,"PPP2CA/PLK1",2
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"STAT3",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"PPP2CA",1
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"EP300",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"SMAD3",1
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"MAPK3",1
"R-HSA-525793","R-HSA-525793","Myogenesis","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"MAPK14",1
"R-HSA-5357956","R-HSA-5357956","TNFR1-induced NFkappaB signaling pathway","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"MAP3K7",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"TP53",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/76","22/2914",0.442074786373165,0.544016643984716,0.367320863458623,"EP300",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/76","23/2914",0.456736721447729,0.557118418469209,0.376167201469963,"SMAD4",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/76","23/2914",0.456736721447729,0.557118418469209,0.376167201469963,"MAPK14",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/76","23/2914",0.456736721447729,0.557118418469209,0.376167201469963,"CHEK1",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/76","23/2914",0.456736721447729,0.557118418469209,0.376167201469963,"E2F1",1
"R-HSA-114608","R-HSA-114608","Platelet degranulation ","2/76","59/2914",0.459176023235102,0.557642654038254,0.376521166121609,"VEGFD/VEGFC",2
"R-HSA-202403","R-HSA-202403","TCR signaling","2/76","59/2914",0.459176023235102,0.557642654038254,0.376521166121609,"MAP3K7/PAK1",2
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","2/76","60/2914",0.467946048742272,0.564611554840877,0.381226578517501,"PPP2CA/PLK1",2
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","1/76","24/2914",0.471018288092479,0.564611554840877,0.381226578517501,"MAP3K7",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/76","24/2914",0.471018288092479,0.564611554840877,0.381226578517501,"EP300",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/76","24/2914",0.471018288092479,0.564611554840877,0.381226578517501,"TP53",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/76","24/2914",0.471018288092479,0.564611554840877,0.381226578517501,"CHEK1",1
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","1/76","24/2914",0.471018288092479,0.564611554840877,0.381226578517501,"JAK2",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","2/76","61/2914",0.476633470823655,0.570111155834328,0.384939917452861,"PPP2CA/PLK1",2
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/76","25/2914",0.484929225845065,0.571232738980168,0.385697212094718,"AKT1",1
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","1/76","25/2914",0.484929225845065,0.571232738980168,0.385697212094718,"MAPK3",1
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","1/76","25/2914",0.484929225845065,0.571232738980168,0.385697212094718,"MAPK3",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/76","25/2914",0.484929225845065,0.571232738980168,0.385697212094718,"NTF4",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/76","25/2914",0.484929225845065,0.571232738980168,0.385697212094718,"AKT1",1
"R-HSA-76005","R-HSA-76005","Response to elevated platelet cytosolic Ca2+","2/76","62/2914",0.485236596795228,0.571232738980168,0.385697212094718,"VEGFD/VEGFC",2
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/76","62/2914",0.485236596795228,0.571232738980168,0.385697212094718,"TP53/JAK2",2
"R-HSA-1430728","R-HSA-1430728","Metabolism","8/76","289/2914",0.485805140177729,0.571232738980168,0.385697212094718,"PPP2CA/AKT1/CSNK2A1/EP300/MED1/STK11/AIP/MAPKAPK2",8
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/76","26/2914",0.498479028141976,0.583662153204212,0.394089571438026,"NOTCH1",1
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","1/76","26/2914",0.498479028141976,0.583662153204212,0.394089571438026,"JAK2",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/76","64/2914",0.502183891083529,0.586762230634439,0.396182748422684,"NOTCH1/EP300",2
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","13/76","486/2914",0.508561526422795,0.587951773068294,0.396985929278924,"RHOA/MAPK3/PPP2CA/AKT1/ROCK2/AKT2/AKT3/PAK1/ARHGEF10/ARHGEF1/ARHGEF2/ARHGEF5/ARHGEF25",13
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/76","27/2914",0.511676948454029,0.587951773068294,0.396985929278924,"CDK1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/76","27/2914",0.511676948454029,0.587951773068294,0.396985929278924,"NOTCH1",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/76","27/2914",0.511676948454029,0.587951773068294,0.396985929278924,"MAP3K7",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/76","27/2914",0.511676948454029,0.587951773068294,0.396985929278924,"EP300",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/76","27/2914",0.511676948454029,0.587951773068294,0.396985929278924,"EP300",1
"R-HSA-75893","R-HSA-75893","TNF signaling","1/76","27/2914",0.511676948454029,0.587951773068294,0.396985929278924,"MAP3K7",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/76","27/2914",0.511676948454029,0.587951773068294,0.396985929278924,"YAP1",1
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","1/76","28/2914",0.524532006270965,0.595327737178703,0.401966191437872,"RHOA",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/76","28/2914",0.524532006270965,0.595327737178703,0.401966191437872,"PLK1",1
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/76","28/2914",0.524532006270965,0.595327737178703,0.401966191437872,"CDK1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/76","28/2914",0.524532006270965,0.595327737178703,0.401966191437872,"EP300",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/76","28/2914",0.524532006270965,0.595327737178703,0.401966191437872,"MED1",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/76","28/2914",0.524532006270965,0.595327737178703,0.401966191437872,"EP300",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/76","29/2914",0.537052992938812,0.607055827048963,0.409885015513382,"CDK1",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/76","29/2914",0.537052992938812,0.607055827048963,0.409885015513382,"EP300",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/76","30/2914",0.549248477353595,0.617070657755558,0.416647044402046,"CSNK2A1",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/76","30/2914",0.549248477353595,0.617070657755558,0.416647044402046,"PPP2CA",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/76","30/2914",0.549248477353595,0.617070657755558,0.416647044402046,"TP53",1
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/76","31/2914",0.561126811514874,0.626610423321439,0.423088308586879,"FGF21",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/76","31/2914",0.561126811514874,0.626610423321439,0.423088308586879,"AKT1",1
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","1/76","31/2914",0.561126811514874,0.626610423321439,0.423088308586879,"PPP2CA",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/76","32/2914",0.572696135942508,0.634423863169844,0.428363955027908,"MED1",1
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","1/76","32/2914",0.572696135942508,0.634423863169844,0.428363955027908,"MAPK3",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/76","32/2914",0.572696135942508,0.634423863169844,0.428363955027908,"EP300",1
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","1/76","32/2914",0.572696135942508,0.634423863169844,0.428363955027908,"MAPK3",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/76","33/2914",0.583964384959985,0.643056019152365,0.434192399844935,"CHEK1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/76","33/2914",0.583964384959985,0.643056019152365,0.434192399844935,"EP300",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/76","33/2914",0.583964384959985,0.643056019152365,0.434192399844935,"AKT1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/76","34/2914",0.594939291847538,0.649982887746819,0.438869432030095,"MAPK3",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/76","34/2914",0.594939291847538,0.649982887746819,0.438869432030095,"EP300",1
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","1/76","34/2914",0.594939291847538,0.649982887746819,0.438869432030095,"MAPK3",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/76","34/2914",0.594939291847538,0.649982887746819,0.438869432030095,"TP53",1
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","2/76","77/2914",0.603401777908876,0.657776435610307,0.444131647372725,"MAPK3/NRG1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/76","35/2914",0.605628393868228,0.657776435610307,0.444131647372725,"MAPK3",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/76","35/2914",0.605628393868228,0.657776435610307,0.444131647372725,"TP53",1
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","1/76","37/2914",0.626178381567251,0.676126462587207,0.456521613430148,"PPP2CA",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/76","37/2914",0.626178381567251,0.676126462587207,0.456521613430148,"EP300",1
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","1/76","37/2914",0.626178381567251,0.676126462587207,0.456521613430148,"EP300",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/76","81/2914",0.631318863755794,0.680353338610613,0.45937560653462,"TP53/CHEK1",2
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/76","38/2914",0.636053405203292,0.684127209084936,0.461923729605002,"MAP3K7",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","1/76","39/2914",0.645670909099171,0.691790259749112,0.467097833040652,"MAP3K7",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/76","39/2914",0.645670909099171,0.691790259749112,0.467097833040652,"EP300",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/76","42/2914",0.673043748103876,0.71972886357929,0.485962020738221,"STAT3",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","2/76","88/2914",0.676517787125945,0.722052638182499,0.487531036876187,"MAPK3/NRG1",2
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/76","43/2914",0.681695793766866,0.726182659386968,0.490319633459954,"MAP3K7",1
"R-HSA-4086400","R-HSA-4086400","PCP/CE pathway","1/76","44/2914",0.690121819428209,0.732347246238348,0.494481971855575,"RHOA",1
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","1/76","44/2914",0.690121819428209,0.732347246238348,0.494481971855575,"PPP2CA",1
"R-HSA-168249","R-HSA-168249","Innate Immune System","10/76","428/2914",0.698129384506525,0.73823209008312,0.498455427348679,"RHOA/MAPK14/MAPK3/PPP2CA/MAP3K7/EP300/STAT6/MAPKAPK2/MYO9B/PAK1",10
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/76","45/2914",0.69832765278133,0.73823209008312,0.498455427348679,"JAK2",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/76","47/2914",0.714101315648177,0.753471920503304,0.508745383971885,"JAK2",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/76","48/2914",0.721680073935843,0.760023607275888,0.513169092821652,"CHEK1",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/76","97/2914",0.728004243794638,0.765231733534137,0.516685627573547,"MAPK3/JAK2",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","3/76","144/2914",0.734960999182843,0.771083846023588,0.520636982805874,"AKT1/AKT2/AKT3",3
"R-HSA-69306","R-HSA-69306","DNA Replication","1/76","51/2914",0.743246743082403,0.778305551718365,0.525513089448531,"E2F1",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/76","53/2914",0.756699464565038,0.787932838336953,0.532013447980949,"CSNK2A1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/76","53/2914",0.756699464565038,0.787932838336953,0.532013447980949,"PAK1",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/76","53/2914",0.756699464565038,0.787932838336953,0.532013447980949,"MAP3K7",1
"R-HSA-112316","R-HSA-112316","Neuronal System","2/76","105/2914",0.767877433906795,0.798074861082905,0.538861357127575,"MAPK3/NRG1",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/76","55/2914",0.769456116685831,0.798220831328292,0.538959916458743,"EP300",1
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","2/76","107/2914",0.777030850551542,0.804574854582287,0.543250162600842,"TP53/EP300",2
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/76","57/2914",0.781552259797295,0.807679967081679,0.54534673927184,"MAP3K7",1
"R-HSA-2990846","R-HSA-2990846","SUMOylation","2/76","109/2914",0.785872518891605,0.807679967081679,0.54534673927184,"TP53/EP300",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/76","109/2914",0.785872518891605,0.807679967081679,0.54534673927184,"EP300/JAK2",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/76","109/2914",0.785872518891605,0.807679967081679,0.54534673927184,"EP300/JAK2",2
"R-HSA-73894","R-HSA-73894","DNA Repair","3/76","157/2914",0.787306058002141,0.807679967081679,0.54534673927184,"TP53/EP300/CHEK1",3
"R-HSA-111885","R-HSA-111885","Opioid Signalling","1/76","59/2914",0.793021660874668,0.810547001446483,0.547282565225127,"PPP2CA",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/76","59/2914",0.793021660874668,0.810547001446483,0.547282565225127,"CHEK1",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","3/76","160/2914",0.798119344543438,0.814257787172073,0.549788093377445,"AKT1/AKT2/AKT3",3
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","6/76","296/2914",0.799992821316581,0.814671588680187,0.550067492783588,"PPP2CA/AKT1/MAP3K7/AKT2/AKT3/PAK1",6
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/76","61/2914",0.803896382782319,0.817147422058951,0.551739179237527,"CSNK2A1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/76","62/2914",0.80912031370014,0.820953883187528,0.554309307567112,"STAT3",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/76","63/2914",0.814206869155536,0.823105304884012,0.555761950760945,"CHEK1",1
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","1/76","63/2914",0.814206869155536,0.823105304884012,0.555761950760945,"MAP3K7",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/76","66/2914",0.828677485303794,0.836210916988374,0.564610879939044,"EP300",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/76","125/2914",0.846273260359538,0.852416804899354,0.575553120045841,"RHOA/MAPK14",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","7/76","393/2914",0.904701655052338,0.909618511873275,0.614175799387171,"TP53/RHOA/SMAD3/CDK1/MAP3K7/EP300/SMAD4",7
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/76","165/2914",0.936144378937107,0.93953007289348,0.634372130773028,"MAPK3/ARHGEF25",2
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/76","121/2914",0.961853679598225,0.963589877575839,0.650617347400661,"FGF21",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","1/76","217/2914",0.997424012266811,0.997424012266811,0.673462206480767,"PPP2CA",1
